In recent years, patients are expecting more targeted, effective and personalized therapies and New Science requires technology to become an integral part of the patient treatment. In addition, agility and responsiveness are more critical for life sciences companies than ever before. For all the tremendous success with the vaccine development, the COVID-19 pandemic has brought new complexity to supply chain and patient engagement models. The industry needs to scale its digital capabilities to address fluctuations in demand and improve resilience across its core operations.
In order to do so, life sciences CIOs have the opportunity to reimagine their technology architectures and extend their ecosystem of partners to disrupt the way they deliver improved outcomes for patients.
Our life sciences technology practice helps navigate this everchanging technology landscape by identifying opportunities for significant capability advances with our enterprise advisory, platform, cloud, data and analytics services.
We combine the power of leading platforms—Google, SAP and more—with our industry intelligence, innovation capabilities to drive large-scale, platform-enabled transformation.
Providing cloud-based solutions across the life sciences enterprise to deliver insights that can lead to better patient outcomes, faster than ever before. Powered by Google Cloud. Learn more.
myConcerto for Life Sciences
An insight-driven, digitally integrated platform that orchestrates the power of new SAP solutions and technologies and can accelerate a move to SAP S/4HANA. Learn more.
Life sciences solutions and services
We help the world’s leading biopharma companies bring their vision to life – enabling them to improve outcomes by converging around the patient, connecting scientific expertise with unique insights into the patient experience.
Cloud First for life sciences
Finding new and better ways to unlock data, increase collaboration, improve engagement and transform your business with the power of cloud computing.
Spotlight on: Life Sciences Technology Vision 2022
The life sciences industry is on the threshold of a new decade of digital transformation, and at a defining moment for all leaders. The Metaverse Continuum will transform how businesses interact with customers and how work is done. Our two surveys of biopharma and medical technology executives confirms this:
91% of MedTech executives believe the metaverse will have a positive impact on their organizations.
42% of biopharma executives believe the metaverse will have a breakthrough or transformational impact on their organizations.
The Metaverse Continuum incorporates all digitally enhanced realities—both social and business-related. It touches all patients, healthcare professionals and enterprises – from reality to virtual and back.
This year’s Accenture Technology Vision explores four trends that reveal how new technology innovations like metaverse are reshaping biopharma and medical technology experiences of the future.
Our deep industry expertise puts us in a unique position to help you use the right technology to address your most complex and critical challenges and accelerate change across your enterprise to create lasting value to your patients.
Helping to unlock powerful analytics insights by tapping into data you didn't even know you had.
Alliances & partners
We utilize our partnerships with the biggest names in technology – as well as innovative startups whose names you might not be familiar with – to provide industry-specific solutions across all phases of the life sciences value chain.
We bring our industry expertise to solve your unique needs. Discover how our recognition and awards distinguish us as the right partner to help you redefine and implement the right technology strategy for your business.